Atlas Trials

Active Comparator-Controlled Study to Assess Safety and Efficacy of ISIS-FXIRx in Total Knee Arthroplasty

Clinical trial NCT01713361 · COMPLETED

Trial details

NCT number
NCT01713361
Sponsor
Ionis Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Venous Thromboembolism
Start date
2012-10-01
Primary completion
2014-05-01
Enrollment
315

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.